A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Unresectable · Locally Advanced · Metastatic Cancers · Relapsed/Refractory Lymphomas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope, Duarte, California, United States
Contact: Study coordinator (Mihae Song) · misong@coh.org · 877-467-3411
Cleveland Clinic, Cleveland, Ohio, United States
Contact: Study coordinator (Jessica Grenbenc) · canceranswer@ccf.org · 216-444-7923
SCRI Oncology Partners - PPDS, Nashville, Tennessee, United States
START Mountain Region, West Valley City, Utah, United States
Contact: Study coordinator (Marie Asay) · marie.asay@startresearch.com · 801-907-4750
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Study coordinator (Anh Nguyen) · anh.nguyen2@uhn.ca · 416-946-4501
McGill University Health Centre (MUHC) - The Montreal, Québec, Canada
Contact: Study coordinator (Phuong-nam Nguyen) · Phuong-nam.Nguyen@muhc.mcgill.ca · 5149341934

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Locally Advanced Unresectable Triple-Negative Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma (PDAC) · Unresectable Locally Advanced or Metastatic Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Nanjing, China

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Invasive Breast Carcinoma

Abroad (travel likely)RecruitingPHASE1

Boston, United States · St Louis, United States